Standard Glass Lining Technology Ltd
Incorporated in September 2012, Standard Glass Lining Technology Limited is a manufacturer of engineering equipment for the pharmaceutical and chemical sectors in India.[1]
- Market Cap ₹ 3,375 Cr.
- Current Price ₹ 169
- High / Low ₹ 214 / 124
- Stock P/E 118
- Book Value ₹ 29.9
- Dividend Yield 0.00 %
- ROCE 8.54 %
- ROE 6.16 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 46.8% CAGR over last 5 years
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding has decreased over last quarter: -12.1%
- Company has a low return on equity of 9.68% over last 3 years.
- Earnings include an other income of Rs.18.3 Cr.
- Debtor days have increased from 86.1 to 106 days.
- Working capital days have increased from 311 days to 472 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Capital Goods-Non Electrical Equipment Industry: Engineering
Part of BSE IPO
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 90 | 127 | 153 | 210 | 209 | 196 | |
| 84 | 112 | 126 | 178 | 173 | 166 | |
| Operating Profit | 6 | 15 | 27 | 32 | 37 | 30 |
| OPM % | 7% | 12% | 18% | 15% | 17% | 15% |
| 0 | 0 | 1 | 4 | 8 | 18 | |
| Interest | 0 | 1 | 3 | 4 | 5 | 6 |
| Depreciation | 1 | 2 | 4 | 4 | 5 | 5 |
| Profit before tax | 5 | 13 | 21 | 27 | 34 | 37 |
| Tax % | 19% | 22% | 25% | 26% | 23% | 23% |
| 4 | 10 | 16 | 20 | 26 | 29 | |
| EPS in Rs | 4.67 | 11.06 | 10.43 | 12.75 | 14.52 | 1.44 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 17% |
| 3 Years: | 9% |
| TTM: | -6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 47% |
| 3 Years: | 22% |
| TTM: | 9% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | 10% |
| Last Year: | 6% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 9 | 9 | 15 | 16 | 18 | 199 |
| Reserves | 4 | 14 | 45 | 98 | 316 | 396 |
| 3 | 18 | 23 | 25 | 50 | 35 | |
| 17 | 41 | 87 | 69 | 61 | 49 | |
| Total Liabilities | 33 | 82 | 171 | 208 | 445 | 679 |
| 12 | 24 | 39 | 36 | 40 | 55 | |
| CWIP | 0 | 0 | 0 | 2 | 3 | 7 |
| Investments | 0 | 0 | 10 | 11 | 49 | 63 |
| 21 | 58 | 122 | 159 | 353 | 555 | |
| Total Assets | 33 | 82 | 171 | 208 | 445 | 679 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 14 | -1 | 1 | 2 | -12 | 7 | |
| -5 | -13 | -41 | -26 | -190 | -223 | |
| -9 | 14 | 40 | 29 | 212 | 200 | |
| Net Cash Flow | -0 | -0 | 0 | 5 | 10 | -15 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 17 | 62 | 70 | 59 | 93 | 106 |
| Inventory Days | 78 | 116 | 326 | 242 | 275 | 326 |
| Days Payable | 90 | 107 | 168 | 129 | 129 | 107 |
| Cash Conversion Cycle | 6 | 70 | 227 | 173 | 239 | 325 |
| Working Capital Days | 20 | 48 | 81 | 122 | 339 | 472 |
| ROCE % | 47% | 39% | 28% | 15% | 9% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
15h - Q4 FY25 Audited Financial results Newspaper Publication
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
15h - Earnings call recording for Q4FY25 uploaded on company website with access link.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
1d - SGLTL reports 13.9% revenue growth, new Japan partnership, Unit-5 commissioned, $130 Cr capex planned.
-
Board Meeting Outcome for Outcome Of Board Meeting_ 23 May 2025
1d - Approved FY25 audited results with unmodified opinion; appointed secretarial and internal auditors for FY26.
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 20 May
Annual reports
No data available.
Concalls
-
Feb 2025Transcript PPT
Business Overview[1] Standard Glass is among the top 5 specialized engineering equipment manufacturers for pharmaceutical and chemical sectors in India (FY24 revenue basis). It provides end-to-end solutions including design, manufacturing, assembly, installation, and commissioning of equipment with over 65+ unique designs and over 11,000 units delivered.